Dr. Anderson is studying cell signaling downstream from receptor tyrosine kinases and the mechanisms cells use to turn off these signals. Her lab is working to understand how the regulation of the tumor suppressor protein, PTEN, a lipid phosphatase that counteracts cell survival and proliferative signals generated by PI3K, contributes to cancer. She is also interested in studying receptor endocytosis, trafficking and degradation pathways to determine the mechanisms used by cells to switch off receptor signaling. More recently, her lab has also been involved in studying the function of the metastasis suppressor protein CREB3L1.